BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22336151)

  • 1. Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study.
    Sgourakis G; Gockel I; Karaliotas C; Moehler M; Schimanski CC; Schmidberger H; Junginger T
    BMC Cancer; 2012 Feb; 12():70. PubMed ID: 22336151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
    Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
    Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-expanding metal stent insertion for inoperable esophageal carcinoma in Belfast: an audit of outcomes and literature review.
    Gray RT; O'Donnell ME; Scott RD; McGuigan JA; Mainie I
    Dis Esophagus; 2011 Nov; 24(8):569-74. PubMed ID: 21418125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insertion of self expanding metal stents with flexible bronchoscopy under sedation for malignant tracheobronchial stenosis: a single-center retrospective analysis.
    McGrath EE; Warriner D; Anderson P
    Arch Bronconeumol; 2012 Feb; 48(2):43-8. PubMed ID: 22137422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
    Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis.
    Lai A; Lipka S; Kumar A; Sethi S; Bromberg D; Li N; Shen H; Stefaniwsky L; Brady P
    Dig Dis Sci; 2018 Apr; 63(4):1025-1034. PubMed ID: 29417326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes.
    Mariette C; Gronnier C; Duhamel A; Mabrut JY; Bail JP; Carrere N; Lefevre JH; Meunier B; Collet D; Piessen G; ;
    J Am Coll Surg; 2015 Mar; 220(3):287-96. PubMed ID: 25617915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer.
    Semrau R; Herzog SL; Vallböhmer D; Kocher M; Hölscher AH; Müller RP
    Dis Esophagus; 2012 Aug; 25(6):545-54. PubMed ID: 22133297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
    Lecleire S; Di Fiore F; Antonietti M; Ben Soussan E; Hellot MF; Grigioni S; Déchelotte P; Lerebours E; Michel P; Ducrotté P
    Gastrointest Endosc; 2006 Oct; 64(4):479-84. PubMed ID: 16996335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.
    Metzger JC; Wollschläger D; Miederer M; Vaupel P; Moehler M; Schmidberger H; Mayer A
    Strahlenther Onkol; 2017 Oct; 193(10):791-799. PubMed ID: 28770295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
    Hurmuzlu M; Monge OR; Smaaland R; Viste A
    Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Esophageal cancer: outcome according to therapeutic strategy].
    Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
    Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.
    Gockel I; Kneist W; Junginger T
    World J Surg; 2006 Feb; 30(2):183-90. PubMed ID: 16425075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.